COVID-19 Provider Resources

While the COVID-19 landscape has improved dramatically in terms of markedly lower hospitalizations and deaths, the continued threat presented by new variants means that COVID-19 will be requiring our attention and efforts for the foreseeable future. Messaging about and administration of COVID-19 vaccines remains critically important as a key prevention strategy. Prompt testing for those who are exposed or symptomatic, as well as rapid access to therapeutics for those at higher risk, is essential. Because the initiation of treatment is so time-sensitive, we encourage providers to look at their office processes to ensure that exposed and/or symptomatic high-risk patients are able to access prompt testing and treatment in an office or telehealth visit. At PHC, we are working with the Department of Health Care Services to help ensure that you have easy access to information and resources you and your patients may need. Please check this page regularly for updated information.

Testing and Treatment


Treatment Options

Pre-exposure prophylaxis: Identifying moderately to severely immunocompromised members, who may qualify for pre-exposure prophylaxis, is critically important. The CDC guidelines as to which patients fit into these categories may be found below. PHC will be reaching out to this group of members.  Your efforts to do the same in your clinical setting will increase the odds that these vulnerable patients will have the opportunity to protect themselves.

Testing: Early testing not only helps to limit exposures to others but also affords an opportunity for higher risk individuals to access timely treatment. Listed below are some useful links.

Note: Oral therapeutics are available through Medi-Cal Rx mail order. Short time frames for beginning effective treatment makes use of mail ordering prescriptions challenging as routine deliveries may take 7-10 days. However, 1-2 day shipping is offered by some retail chains.  Providers will need to verify delivery time frames available locally before using this resource. 

Infusion Centers Offering COVID-19 Therapeutics: Sites offering Evusheld and Bebtelovimab (in addition to Paxlovid and Molnupiravir) are linked below. A list of sites offering Remdesivir is not currently available through federal or CDPH websites; PHC's list of sites which have billed for Remdesivir infusion may be found below. In addition, providers are encouraged to reach out to their local hospital, infusion centers, or local health department to identify access points for Remdesivir infusion.

Register to become a "Test to Treat" Provider:



​Additional Resources

COVID-19 Telehealth Provider Webinar 04/29/2020:

Recording
Material

 

Vaccination and Resources


Facts about COVID-19 vaccination and information on getting the COVID vaccine or booster:

Department of Health Care Services (DHCS): The following is guidance and information provided by DHCS for health plans and providers.